The Department of Obstetrics and Gynecology at The Second Norman Bethune Hospital of Jilin University was founded in 1936. Under the leadership of generations of experts, including Professor Yin Yuzhang, and through 89 years of dedication and perseverance, the department has continuously grown and developed. It is now a nationally renowned discipline integrating clinical practice, teaching, and scientific research. It ranks first in Jilin Province on the latest list of Chinese hospitals and specialties reputations released by the Hospital Management Institute of Fudan University.
The department plays a significant leading and demonstrative role in the region. It is recognized as: one of the first National Key Standardized Residency Training Bases for Obstetrics and Gynecology; a National Regional Medical Center for Obstetrics and Gynecology established through joint provincial and national commission efforts; a branch center of the National Clinical Research Center for Obstetric and Gynecologic Diseases; and the only flagship integrated Traditional Chinese and Western Medicine department for obstetrics and gynecology among tertiary Grade A general hospitals in Northeast China, approved by the National Health Commission. It has been approved as a National Key Clinical Specialty Construction Project. The department serves as the leading unit for the Jilin Province Obstetrics and Gynecology Medical Quality Control Center. It spearheads the establishment of the Jilin Provincial Clinical Research Center for Obstetric and Gynecologic Diseases, the Jilin Provincial Cross-Regional Sci-Tech Innovation Center for Cervical Disease Diagnosis & Treatment and Novel Bioscreening Technology Research, and the Jilin Provincial Critical Maternal Care Center. It houses the Jilin Provincial Key Laboratory for Targeted Diagnosis and Treatment of Gynecological Oncology and the Jilin Provincial Key Laboratory of Reproductive Medicine and Birth Health. The discipline leaders hold positions as standing committee members of the Obstetrics and Gynecology Society of the Chinese Medical Association and the Chinese Physician Association Obstetricians and Gynecologists Branch, and as chairs of the Jilin Provincial Obstetrics and Gynecology Society, the Jilin Perinatal Medicine Society, and the Jilin Physician Association Reproductive Medicine Branch.
The department boasts balanced disciplinary development and a comprehensive team of technical professionals. It comprises Gynecology, Obstetrics, and a Reproductive Medicine Center, providing full-spectrum, whole-cycle healthcare for women. The team consists of 403 members, including authoritative experts, doctors, nurses, and technicians: 117 physicians and 285 nurses and technicians. This includes 14 doctoral supervisors and 29 master's supervisors, 28 with senior professional titles and 25 with associate senior titles. The department has 438 open beds, handles over 480,000 outpatient visits annually, admits over 28,000 inpatients per year, and assists in over 9,600 deliveries annually. Furthermore, it continuously strengthens external collaboration, promotes the expansion and下沉 (sinking) of high-quality medical resources and regional balanced distribution, and actively undertakes the diagnosis and treatment of complex and critical obstetric and gynecological cases, primarily within Jilin Province while also radiating to surrounding provinces and autonomous regions. In 2022, it was approved for the Provincial High-Level Obstetrics and Gynecology Construction Project (250 million CNY), and in 2024, it was approved for the Gynecological Tumor Precision Diagnosis and Treatment Innovation Research Center.
I. Innovating Medical Development, Building New Heights in Medical Technology
The department pioneered the standardized and minimally invasive diagnosis and treatment of gynecological malignancies in the province, as well as fertility-preserving surgeries and surgeries for pelvic floor dysfunction disorders. It was the first to introduce single-port laparoscopy and promote it throughout the province, benefiting female patients in Jilin and enhancing the clinical diagnostic and treatment capabilities of obstetricians and gynecologists across the province. Subspecialties including gynecological oncology, general gynecology, gynecological endocrinology, and gynecological pelvic floor disorders develop in tandem, handling approximately 28,000 inpatients and over 20,000 surgeries annually. The Obstetrics department brings together five provincial centers: Perinatal Medicine, Prenatal Diagnosis, High-Risk Pregnancy Diagnosis, Critical Maternal Care, and a Miscarriage Prevention Alliance. It serves as the chair unit of the Northeast Obstetrics Alliance. It has extensive experience in managing deliveries for advanced maternal age, pregnancies complicated by malignancies, splenic artery aneurysms, and other complex and rare obstetric conditions. The Reproductive Medicine Center pioneered the use of cytogenetics and molecular biology techniques for prenatal genetic diagnosis of hereditary diseases in the province. It was the first to perform in vitro fertilization-embryo transfer (IVF/ICSI-ET), resulting in the province's first test-tube baby, first successful multifetal pregnancy reduction, and successful pregnancy for the oldest woman in the province at the time, filling multiple gaps in assisted reproductive technology in Jilin.
II. Cultivating Elite Talent, Exploring New Paths in Scientific Research
The department adheres to the principle of cultivating talent for the Party and the country. In undergraduate education, the Obstetrics and Gynecology teaching faculty undertakes nearly 200 teaching hours annually for over 500 students. It was approved as a master's degree granting site in obstetrics and gynecology in 1978 and a doctoral degree granting site in 1986. In recent years, it has trained over 380 master's students, over 30 doctoral students, and over 350 standardized residency trainees who have completed their training. It has won important honors such as the third prize in the National College Faculty Teaching Innovation Competition and the second prize in the National Micro-course Teaching Competition. Its courses have been selected as Ministry of Education Fine Video Open Courses and Jilin Provincial Level Fine Courses.
Over the past five years, the department has undertaken 4 National Natural Science Foundation projects and over 90 provincial/ministerial-level research projects. It has published over 270 papers, including more than 80 SCI-indexed papers, over 10 books, and obtained over 30 invention and utility model patents. It has received multiple provincial/ministerial scientific achievement awards and Jilin University Medical Achievement awards (including the first prize of the Jilin Provincial Science and Technology Progress Award). Focusing closely on public needs and academic frontiers, it comprehensively promotes the advancement and development of obstetrics and gynecology.
III. Patient-Centered Care, Building a New Model of Medical Service
The Department of Obstetrics and Gynecology at The Second Norman Bethune Hospital of Jilin University始终坚持 (always adheres to) a "patient-centered" service philosophy, emphasizing the combination of medical quality and humanistic care. Leveraging advanced information technologies like big data analysis and telemedicine, it has built a comprehensive smart healthcare system. Since 2021, it has taken the lead domestically in establishing a "One-Stop Intelligent" Cervical Cancer Prevention and Control Platform and an Ovarian Cancer Single-Disease Standardized Diagnosis, Treatment, and Management Platform. By integrating big data, artificial intelligence, and other IT technologies with clinical application, it has digitized, intelligentized, and visualized medical information. It has created structured electronic medical records for cervical and ovarian cancer screening, specialized disease databases, and EDC follow-up systems, achieving full-cycle, full-process信息化 (informatized) intelligent management from prevention to treatment to follow-up for cervical and ovarian cancer. This contributes significantly to the diagnosis, treatment, and management of gynecological malignancies in Jilin Province and markedly enhances patient satisfaction.
Standing at a new historical starting point, the Department of Obstetrics and Gynecology at The Second Norman Bethune Hospital of Jilin University will continue to adhere to connotative high-quality development, constantly improve medical技术水平 (technical proficiency), optimize medical service models, strengthen talent team building, and expand the specialty's辐射 (radiation) capacity. It aims to better serve the high-quality development of the hospital and the Healthy China strategy, safeguarding the health of women.
Subordinate Departments:
Obstetrics
Prenatal Diagnosis Center
Gynecology
Obstetrics and Gynecology Research Office
Reproductive Medicine Center
Department Characteristics:
The department's distinctive features primarily include comprehensive treatment, predominantly surgical, for benign and malignant gynecological tumors; minimally invasive techniques such as laparoscopy, hysteroscopy, vaginal surgery, and interventional therapy; corrective surgery for female reproductive tract malformations and repair surgery for organ damage diseases; pelvic floor reconstruction, treatment of gynecological endocrine diseases; management of high-risk pregnancies; assisted reproductive technologies (artificial insemination and IVF for infertility), maternal-fetal blood flow monitoring, prenatal diagnosis; diagnosis and treatment of high-risk pregnancies, and rescue of critically ill patients. The comprehensive level of the department ranks first in the province and leads domestically, aligning with international standards and forming unique diagnostic and treatment characteristics and development models.
In recent years, the Department of Obstetrics and Gynecology at The Second Norman Bethune Hospital of Jilin University has continuously increased investment. Research achievements are mainly reflected in:
Diagnosis and treatment of gynecological malignancies: Including early diagnosis and comprehensive treatment (surgery, chemotherapy, radiotherapy, interventional therapy) for endometrial cancer, ovarian cancer, cervical cancer, etc. Particularly in ovarian cancer treatment research, a series of results have been achieved, placing it at the domestic forefront. Research on the application of pre-targeting technology for early diagnosis and immune-targeted therapy of ovarian cancer won the Jilin Provincial Science and Technology Progress Award. This research首次 (for the first time) utilized pre-targeting technology for radioimmunoimaging of a humanized ovarian cancer single-chain antibody, providing a new method for early diagnosis and an experimental basis for targeted therapy, especially for recurrent ovarian癌 (cancer).同时 (Simultaneously), it independently designed, innovatively constructed, and expressed a novel recombinant toxin with "one target, dual effects," providing a全新的 (completely new) design concept and approach for developing new targeted drugs for ovarian cancer. Ongoing research on HSAg-CTL for individualized treatment of ovarian cancer patients has also achieved preliminary results with good economic and social benefits. Related research has received two National Natural Science Foundation grants and two Ministry of Education special research基金 (funds). The research level is domestically leading, and this series of研究成果 (research achievements) has been well regarded by domestic experts and peers.
Application of minimally invasive technology in gynecological diseases: Laparoscopic surgery has become a routine and proficient diagnostic and treatment method. It can perform surgeries for various gynecological diseases like uterine fibroids, ovarian tumors, and endometriosis, as well as repair surgeries for pelvic floor dysfunction disorders. Particularly in recent years, the department has applied laparoscopic surgery to the treatment of gynecological malignancies (e.g., cervical cancer, endometrial cancer). Laparoscopically performed radical hysterectomy for endometrial and cervical cancer with pelvic lymphadenectomy is domestically leading and was unprecedented in the province and Northeast China. Hysteroscopy: Diagnoses diseases within the uterine cavity causing abnormal vaginal bleeding, overcoming missed and misdiagnoses from ultrasound or D&C, allowing direct etiological diagnosis. Colposcopy & High-Frequency Electrosurgery: Colposcopy配合 (combined with) gynecological examination, liquid-based cytology, Bethesda reporting system, and pathological examination enables early diagnosis of cervical cancer and precancerous lesions. Interventional Therapy: Super-selective arterial embolization successfully rescues and treats bleeding in advanced gynecological cancers (e.g., uterine bleeding from choriocarcinoma, invasive mole) and intractable postpartum hemorrhage. This is the only program in the province offering this. Continuous infusion chemotherapy via super-selective arterial catheterization treats advanced cancer patients or those难以耐受 (unable to tolerate) surgery (e.g., advanced cervical cancer, choriocarcinoma, ovarian cancer). Vaginal Surgery: Performs myomectomy, subtotal hysterectomy, total hysterectomy, and corrections for uterine prolapse, anterior/posterior vaginal wall prolapse, and stress urinary incontinence transvaginally without laparotomy. Only a few hospitals in the province perform these, but they have become routine and proficient surgeries at this department.
Services at the Reproductive Medicine Center include: (1) Diagnosis and treatment of female infertility; (2) Diagnosis and treatment of male infertility; (3) Assisted reproductive technologies: Intrauterine Insemination (IUI), In Vitro Fertilization—Embryo Transfer (IVF/Test-tube Baby), Intracytoplasmic Sperm Injection (ICSI); (4) Ovulation monitoring, ovulation induction medication, follicular puncture for assisted ovulation; (5) Semen analysis, sperm morphology analysis, epididymal puncture, semen cryopreservation, genetic testing; (6) Preconception counseling, genetic disease screening, diagnosis and treatment of habitual abortion; (7) Minimally invasive treatment of adnexal cysts; (8) Multifetal pregnancy reduction.
The Prenatal Diagnosis Center, besides routinely offering prenatal screening and diagnosis through Down syndrome serum screening, systematic ultrasound, 3D/4D ultrasound, also provides fetal echocardiography, targeted fetal ultrasound, maternal-fetal Doppler flow monitoring, NT screening, etc. It enables prenatal diagnosis of fetuses with major organ defects like Down syndrome, neural tube defects, severe encephalocele, severe open spina bifida, single ventricle heart, lethal achondroplasia in early pregnancy. It provides imaging diagnosis for complex fetal congenital heart disease and prenatal monitoring of placental function and fetal well-being for high-risk pregnant women to better serve them.
Perinatal Medicine primarily focuses on research in this field. Its diagnosis and comprehensive treatment of pregnancy-specific diseases (e.g., hypertensive disorders of pregnancy, HELLP syndrome, intrahepatic cholestasis of pregnancy), pregnancy complications (e.g., heart disease, diabetes, severe hepatitis, hematological diseases, hyperthyroidism), and management of obstetric emergencies like placenta previa, placental abruption, and postpartum hemorrhage are at the domestic leading level.
